For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Oculeve, Inc.

USPTO Granted Patents = 33

% Expired Patents = 24.2

EPO Patents = 6

Forward Citations = 748

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

James Donald Loudin (29 out of 47 patents)

Douglas Michael Ackermann (16 out of 34 patents)

Manfred Franke (14 out of 45 patents)

4. John L Wardle (12 out of 77 patents)

5. Janusz Kuzma (11 out of 20 patents)

6. Douglas Michael Ackermann, Jr (8 out of 42 patents)

7. Daniel N Hamilton (8 out of 22 patents)

8. Christopher William Stivers (5 out of 5 patents)

9. Jarren Armond Baldwin (4 out of 11 patents)

10. Amitava Gupta (3 out of 117 patents)

11. Daniel V Palanker (3 out of 83 patents)

12. John W Lai (3 out of 18 patents)

13. Scott Franklin Wetenkamp (3 out of 5 patents)

14. Marie Dvorak Christ (3 out of 8 patents)

15. Mark Jeffrey Holdbrook (3 out of 3 patents)

33 patents: Sort by Forward Citations

1. 10967173 - Nasal stimulation devices and methods for treating dry eye (2021-04-06),

2. 10940310 - Nasal stimulation for rhinitis, nasal congestion, and ocular allergies (2021-03-09),

3. 10918864 - Intranasal stimulation for treatment of meibomian gland disease and blepharitis (2021-02-16),

4. D907791 - Nasal stimulator body (2021-01-12),

5. 10835748 - Stimulation devices and methods (2020-11-17),

6. 10835738 - Nasal stimulation devices and methods (2020-11-17),

7. 10799696 - Polymer formulations for nasolacrimal stimulation (2020-10-13),

8. 10799695 - Nasal stimulation devices and methods (2020-10-13),

9. 10780273 - Stimulation devices and methods for treating dry eye (2020-09-22),

10. 10722713 - Stimulation patterns for treating dry eye (2020-07-28),

11. 10610695 - Implantable device for increasing tear production (2020-04-07),

12. 10610095 - Apparatus and method for dry eye forecast and treatment recommendation (2020-04-07),

13. 10537469 - Implant delivery devices, systems, and methods (2020-01-21),

14. 10426958 - Intranasal stimulation for enhanced release of ocular mucins and other tear proteins (2019-10-01),

15. 10328262 - Stimulation devices and methods (2019-06-25),

Oculeve, Inc. is a biotechnology company based in South San Francisco, California, specializing in innovative solutions for ocular health. The company focuses on developing advanced medical devices and therapeutics aimed at treating dry eye disease and other related conditions. By leveraging cutting-edge research in ophthalmology, Oculeve aims to enhance patient care and improve the quality of life for individuals suffering from chronic eye conditions. Their commitment to innovation positions them as a key player in the medical device sector.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

33 Patents

#42 in South San Francisco, CA

#2,458 in California

#10,288 in US

#20,112 in the World

South San Francisco, CA, United States of America

Oculeve, Inc.

Forward Citations = 748

23 inventors:

James Donald Loudin (29 out of 47 patents)

Douglas Michael Ackermann (16 out of 34 patents)

Manfred Franke (14 out of 45 patents)

4. John L Wardle (12 out of 77 patents)

5. Janusz Kuzma (11 out of 20 patents)

Please report any incorrect information to [email protected]

Loading…